Page last updated: 2024-09-02

deguelin and Acute Myelogenous Leukemia

deguelin has been researched along with Acute Myelogenous Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Fang, J; He, J; Hu, J; Ruan, J; Wen, L; Yi, S; Zhang, X; Zhao, Z1
Chen, Y; Cui, G; Fang, J; He, J; Hu, JY; Wang, YP; Wen, L; Yi, S; Zhang, BP; Zhang, C; Zhao, F; Zhao, Z1

Other Studies

2 other study(ies) available for deguelin and Acute Myelogenous Leukemia

ArticleYear
Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro.
    Anti-cancer drugs, 2017, Volume: 28, Issue:7

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Female; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Nucleophosmin; Random Allocation; Rotenone; Xenograft Model Antitumor Assays

2017
Nontoxic-dose of deguelin induce NPMc+ AML cell differentiation by selectively targeting Mt NPM1/SIRT1 instead of HDAC1/3.
    Current cancer drug targets, 2014, Volume: 14, Issue:8

    Topics: Apoptosis; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Granulocytes; Histone Deacetylase 1; Histone Deacetylases; Humans; Leukemia, Myeloid, Acute; Monocytes; Nuclear Proteins; Nucleophosmin; Proteasome Endopeptidase Complex; Receptors, Granulocyte Colony-Stimulating Factor; Rotenone; Sirtuin 1; Ubiquitin

2014